Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease

By Azam Faizul   Barodia Sandeep Kumar   Anwer Tarique   Alam M. M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 3, 2009-06 ,pp. : 808-817

Informa Healthcare

Access to resources Recommend Favorite

Upregulation of the Anti-apoptotic Protein Bcl-2 May Be an Early Event in Neurodegeneration: Studies on Parkinson's and Incidental Lewy Body Disease

By Marshall K.A.   Daniel S.E.   Cairns N.   Jenner P.   Halliwell B.  

Biochemical and Biophysical Research Communications, Vol. 240, Iss. 1, 1997-11 ,pp. : 84-87

Elsevier

Access to resources Recommend Favorite

Gene therapy for Parkinson’s disease

By Le Hoang N   Frim David M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 151-161

Informa Healthcare

Access to resources Recommend Favorite

NMR Metabolomics Analysis of Parkinson's Disease

By  

Current Metabolomics, Vol. 1, Iss. 3, 2013-08 ,pp. : 191-209

Bentham Science Publishers

Access to resources Recommend Favorite

(E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson&unknown;s Disease - Central stimulants acting as preferential dopamine autoreceptor antagonists

By Selley M.L.  

Free Radical Biology and Medicine, Vol. 25, Iss. 2, 1998-07 ,pp. : 169-174

Elsevier

Access to resources Recommend Favorite